Transcatheter vs. surgical aortic valve replacement: A retrospective analysis assessing clinical effectiveness and safety

Journal of Cardiovascular Medicine

Volumn 13, Issue 4, 2012, Pages 229-241

  Fusari, Melissa ^a   Bona, Veronica ^a   Muratori, Manuela ^a   Salvi, Luca ^a   Salis, Stefano ^a   Tamborini, Gloria ^a   Biglioli, Paolo ^a  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

Author keywords

aortic stenosis; aortic valve replacement; transcatheter aortic valve implantation

Indexed keywords

ACETYLSALICYLIC ACID; TICLOPIDINE;

AGED; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; CLINICAL EFFECTIVENESS; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART DEATH; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PLEURA EFFUSION; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; SURGICAL AORTIC VALVE REPLACEMENT; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CHI-SQUARE DISTRIBUTION; FEMALE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; ITALY; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PROPENSITY SCORE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84858774215     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3283515c0f     Document Type: Article

References (31)

1. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2006; 114:e84-e231.
2. Pai RG, Kapoor N, Bansal RC, et al. Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement. Ann Thorac Surg 2006; 82:2116-2122.
3. Charlson E, Legedza AT, Hamel MB. Decision-making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis 2006; 15:312-321.
4. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005; 26:2714-2720 (Pubitemid 41746694)
5. Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005; 111:3290-3295. (Pubitemid 40875002)
6. Thielmann M, Wendt D, Eggebrecht H, et al. Transcatheter aortic valve implantation in patients with very high risk for conventional aortic valve replacement. Ann Thorac Surg 2009; 88:1468-1474.
7. Piazza N, van Gameren M, Jüni P, et al. A comparison of patients characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of aortic stenosis: A two-centre study. EuroIntervention 2009; 5:580-588.
8. Bose AK, Aitchison JD, Dark JH. Aortic valve replacement in octogenarians. J Cardiothorac Surg 2007; 2:33-35.
9. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106:3006-3008. (Pubitemid 35440280)
10. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies -the French experience. J Am Coll Cardiol 2006; 47:1214-1223.
11. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010; 122:62-69.
12. SmithCR,LeonMB,Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364:2187-2198.
13. Desai ND, Christakis GT. Bioprosthetic Aortic valve replacement: stented pericardial and porcine valves. In: Cohn LH, editor. Cardiac surgery in the adult. 3rd ed. New York, New York: McGraw-Hill; 2008. pp. 857-894.
14. Nashef SA, Roques F, Hammill BG, et al. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg 2002; 22:101-105. (Pubitemid 34743720)
15. Fried LP, Tangen CM, Walston J, et al., Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56:M146-M156. (Pubitemid 32187141)
16. Ye J, Cheung A, Lichtenstein SV, et al. Transapical aortic valve implantation in humans. J Thorac Cardiovasc Surg 2006; 131:1194-1196.
17. Fusari M, Alamanni F, Bona V, et al. Transcatheter aortic valve implantation in the operating room: early experience. J Cardiovasc Med (Hagerstown) 2009; 10:383-393.
18. Webb JG, Pasupati S, Achtem L, et al. Rapid pacing to facilitate transcatheter prosthetic heart valve implantation. Catheter Cardiovasc Interv 2006; 68:199-204. (Pubitemid 44167668)
19. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116:755-763. (Pubitemid 47255993)
20. Akins CW, Turina MI, Kouchoukos NT, et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. Eur J Cardiothorac Surg 2008; 33:523-528.
21. Webb JG, Altwegg L, Boone RH, et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 2009; 119:3009-3016.
22. Yan TD, Cao C, Martens-Nielsen J, et al. Transcatheter aortic valve implantation for high-risk patients with severe aortic stenosis: A systematic review. J Thorac Cardiovasc Surg 2010; 139:1519-1528.
23. Rallidis LS, Moyssakis IE, Ikonomidis I, et al. Natural history of early aortic paraprosthetic regurgitation: A five-year follow-up. Am Heart J 1999; 138:351-357. (Pubitemid 29379690)
24. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70:41-55.
25. Uchino SBR, Goldsmith D, Bates S, et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006; 34:1913-1917. (Pubitemid 43982467)
26. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011; 123:299-308.
27. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: A consensus report from the Valve Academic Research Consortium. Eur Heart J 2011; 32:205-217.
28. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: A position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008; 29:1463-1470. (Pubitemid 351806497)
29. Zierer A, Wimmer-Greinecker G, Martens S, et al. Is transapical aortic valve implantation really less invasive than minimally invasive aortic valve replacement? J Thorac Cardiovasc Surg 2009; 138:1067-1072
30. Grube E, Buellesfeld L, Mueller R, et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Interv 2008; 1:167-175.
31. Osswald BR, Gegouskov V, Badowski-Zyla D, et al. Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J 2009; 30:74-80.